PREVAIL Study
What is the PREVAIl Study?
The Leadership Sinai Centre for Diabetes is interested in researching therapies to protect the cells in the body that produce insulin in order to slow the progression of diabetes. We are inviting participants to join our research study.
WHO CAN PARTICIPATE IN THE PREVAIL STUDY?
Adults aged 30 to 80 years
Who have had Type 2 diabetes for 0-7 years
Who currently take 0-2 oral medications for diabetes
WHAT DOES PARTICIPATION IN THE PREVAIL STUDY INVOLVE?
The PREVAIL trial involves randomly assigning participants to one of three therapies for a period of 8 weeks and then promoting a healthy lifestyle for a further 12 weeks.
Participation involves 4 study visits over the 20-week study period.
HOW IS THE PREVAIL TRIAL BEING PAID FOR?
The study is being funded by grants from:
Canadian Institutes of Health Research (CIHR)
University of Toronto Banting and Best Diabetes Centre
Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research
University of Toronto Faculty of Medicine
ARE THERE ANY COSTS TO PARTICIPATE IN THE PREVAIL TRIAL?
Study medications and supplies will be provided to study participants at no cost. We will reimburse study participants for local TTC travel or parking.
How do i get more information?
Contact the Research Coordinator, Alexandra Emery:
Telephone: 416 586-4800, Extension number: 8778
Who is the principAL investigator of the study?
Principal Investigator: Dr Ravi Retnakaran
